Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia

B-cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) are members of the tumor necrosis factor superfamily of cytokines and can induce B cell activation, differentiation, and antibody production via interaction with their receptors, including transmembrane activator, calcium mo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wael Alturaiki, Ayman Mubarak, Sajad Ahmad Mir, Adnan Afridi, Mariappan Premanathan, Suresh Mickymaray, Rajendran Vijayakumar, Suliman A. Alsagaby, Sami G. Almalki, Fayez Alghofaili, Ahmad K. Alnemare, Brian F. Flanagan
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
IgE
Acceso en línea:https://doaj.org/article/743e07eb15f3482aad46de745f21ea6c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:743e07eb15f3482aad46de745f21ea6c
record_format dspace
spelling oai:doaj.org-article:743e07eb15f3482aad46de745f21ea6c2021-11-20T04:57:05ZPlasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia1319-562X10.1016/j.sjbs.2021.08.044https://doaj.org/article/743e07eb15f3482aad46de745f21ea6c2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1319562X21007324https://doaj.org/toc/1319-562XB-cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) are members of the tumor necrosis factor superfamily of cytokines and can induce B cell activation, differentiation, and antibody production via interaction with their receptors, including transmembrane activator, calcium modulator, and cyclophilin ligand interactor (TACI), B-cell maturation antigen (BCMA), and B-cell activating factor receptor (BAFF-R). Herein, we assessed the plasma protein levels of BAFF and APRIL in patients with asthma to determine whether their expression is correlated with total IgE production and examined the surface expression of BAFF/APRIL receptors on B cells. Blood samples were collected from 47 patients with controlled asthma symptoms and 20 healthy normal controls, and plasma levels of APRIL, BAFF, and total IgE protein were quantified by corresponding ELISA assays. Furthermore, lymphocytes were isolated and B cells were analyzed for the presence of BAFF-R, BCMA, and TACI receptors using flow cytometry. Our results showed that IgE, BAFF, and APRIL plasma levels were markedly increased in patients with asthma compared with healthy controls. Moreover, expression of BAFF-R and BCMA, but not that of TACI, was significantly increased in patients with asthma compared with healthy controls. Overall, the findings suggest BAFF and APRIL as key mediators of asthma, and determination of their plasma levels may be useful in monitoring asthma symptoms and treatment response.Wael AlturaikiAyman MubarakSajad Ahmad MirAdnan AfridiMariappan PremanathanSuresh MickymarayRajendran VijayakumarSuliman A. AlsagabySami G. AlmalkiFayez AlghofailiAhmad K. AlnemareBrian F. FlanaganElsevierarticleAsthmaIgEB cellBAFFAPRILBiology (General)QH301-705.5ENSaudi Journal of Biological Sciences, Vol 28, Iss 12, Pp 7455-7459 (2021)
institution DOAJ
collection DOAJ
language EN
topic Asthma
IgE
B cell
BAFF
APRIL
Biology (General)
QH301-705.5
spellingShingle Asthma
IgE
B cell
BAFF
APRIL
Biology (General)
QH301-705.5
Wael Alturaiki
Ayman Mubarak
Sajad Ahmad Mir
Adnan Afridi
Mariappan Premanathan
Suresh Mickymaray
Rajendran Vijayakumar
Suliman A. Alsagaby
Sami G. Almalki
Fayez Alghofaili
Ahmad K. Alnemare
Brian F. Flanagan
Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia
description B-cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) are members of the tumor necrosis factor superfamily of cytokines and can induce B cell activation, differentiation, and antibody production via interaction with their receptors, including transmembrane activator, calcium modulator, and cyclophilin ligand interactor (TACI), B-cell maturation antigen (BCMA), and B-cell activating factor receptor (BAFF-R). Herein, we assessed the plasma protein levels of BAFF and APRIL in patients with asthma to determine whether their expression is correlated with total IgE production and examined the surface expression of BAFF/APRIL receptors on B cells. Blood samples were collected from 47 patients with controlled asthma symptoms and 20 healthy normal controls, and plasma levels of APRIL, BAFF, and total IgE protein were quantified by corresponding ELISA assays. Furthermore, lymphocytes were isolated and B cells were analyzed for the presence of BAFF-R, BCMA, and TACI receptors using flow cytometry. Our results showed that IgE, BAFF, and APRIL plasma levels were markedly increased in patients with asthma compared with healthy controls. Moreover, expression of BAFF-R and BCMA, but not that of TACI, was significantly increased in patients with asthma compared with healthy controls. Overall, the findings suggest BAFF and APRIL as key mediators of asthma, and determination of their plasma levels may be useful in monitoring asthma symptoms and treatment response.
format article
author Wael Alturaiki
Ayman Mubarak
Sajad Ahmad Mir
Adnan Afridi
Mariappan Premanathan
Suresh Mickymaray
Rajendran Vijayakumar
Suliman A. Alsagaby
Sami G. Almalki
Fayez Alghofaili
Ahmad K. Alnemare
Brian F. Flanagan
author_facet Wael Alturaiki
Ayman Mubarak
Sajad Ahmad Mir
Adnan Afridi
Mariappan Premanathan
Suresh Mickymaray
Rajendran Vijayakumar
Suliman A. Alsagaby
Sami G. Almalki
Fayez Alghofaili
Ahmad K. Alnemare
Brian F. Flanagan
author_sort Wael Alturaiki
title Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia
title_short Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia
title_full Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia
title_fullStr Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia
title_full_unstemmed Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi Arabia
title_sort plasma levels of baff and april are elevated in patients with asthma in saudi arabia
publisher Elsevier
publishDate 2021
url https://doaj.org/article/743e07eb15f3482aad46de745f21ea6c
work_keys_str_mv AT waelalturaiki plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia
AT aymanmubarak plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia
AT sajadahmadmir plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia
AT adnanafridi plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia
AT mariappanpremanathan plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia
AT sureshmickymaray plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia
AT rajendranvijayakumar plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia
AT sulimanaalsagaby plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia
AT samigalmalki plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia
AT fayezalghofaili plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia
AT ahmadkalnemare plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia
AT brianfflanagan plasmalevelsofbaffandaprilareelevatedinpatientswithasthmainsaudiarabia
_version_ 1718419722085597184